Home/Filings/4/0001415889-22-001325
4//SEC Filing

Bookman Michael 4

Accession 0001415889-22-001325

CIK 0001790340other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:29 PM ET

Size

5.3 KB

Accession

0001415889-22-001325

Insider Transaction Report

Form 4
Period: 2022-02-10
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
Transactions
  • Award

    Stock Option

    2022-02-10+47,30047,300 total
    Exercise: $9.66Exp: 2032-02-09Class A Common Stock (47,300 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026.

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1
  • filerCIK 0001840339

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:29 PM ET
Size
5.3 KB